<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184973</url>
  </required_header>
  <id_info>
    <org_study_id>CLD-075</org_study_id>
    <nct_id>NCT04184973</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of the CG-100 Intraluminal Bypass Device</brief_title>
  <official_title>Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colospan Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colospan Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation&#xD;
      rate in subjects undergoing mesorectal excision.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A primary diverting stoma is widely used by surgeons in order to bypass the low rectal&#xD;
      anastomosis and reduce morbidity associated with anastomotic leaks. Today a stoma is created&#xD;
      for all high-risk patients even though the expected anastomotic leak rate is less than 20%.&#xD;
      This means that 80% of patients are exposed to potentially serious complications associated&#xD;
      with the stoma itself without any clinical benefit.&#xD;
&#xD;
      CG-100, a removable, temporary intraluminal bypass device, developed by Colospan, is designed&#xD;
      to address this need by safely postponing the creation of a protective stoma until 10 days&#xD;
      after surgery only for patients who need it (i.e. have a defect in the anastomosis); thereby&#xD;
      allowing patients with an intact anastomosis a quicker and safer return to normal activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Stoma creation rate</measure>
    <time_frame>39 Weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>39 Weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Rectal Tumor</condition>
  <condition>Rectal/Anal</condition>
  <arm_group>
    <arm_group_label>CG-100</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive CG-100 during rectal cancer surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SOC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive a protective stoma during rectal cancer surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CG-100 intraluminal bypass device</intervention_name>
    <description>a removable, temporary intraluminal bypass device, developed by Colospan, is designed to safely postpone the creation of a protective stoma until 10 days after surgery only for patients who need it (i.e. have a defect in the anastomosis)</description>
    <arm_group_label>CG-100</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stoma</intervention_name>
    <description>Primary protective ileostomy</description>
    <arm_group_label>SOC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patient is willing to comply with protocol-specified follow-up evaluations&#xD;
&#xD;
          2. Patient 22-65 years of age at screening, or patient 66-70 years of age at screening&#xD;
             with up to one cardiovascular, metabolic or pulmonary comorbidity for which medication&#xD;
             is prescribed.&#xD;
&#xD;
          3. Patient is diagnosed with colorectal cancer&#xD;
&#xD;
          4. Patient is scheduled for elective either open, laparoscopic or robotic with mesorectal&#xD;
             excision (either abdominal or transanal approach) which will require the creation of&#xD;
             an anastomosis, maximally 10 cm from the anal verge&#xD;
&#xD;
          5. Patients who are scheduled to receive a protective stoma under routine clinical&#xD;
             practice during their primary planned operation.&#xD;
&#xD;
          6. Patient is scheduled to undergo mechanical bowel preparation&#xD;
&#xD;
          7. The patient has been informed of the nature of the study, agrees to its provisions and&#xD;
             has provided written informed consent, approved by the appropriate Medical Ethics&#xD;
             Committee (EC) or Institutional Review Board (IRB).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has local or systemic infection at the time of intervention (e.g.,&#xD;
             peritonitis)&#xD;
&#xD;
          2. Major surgical or interventional procedures within 45 days prior to this study or&#xD;
             planned surgical or interventional procedures within 6 months of entry into this study&#xD;
             (not including, placement of port for chemotherapy or ureter stent insertion).&#xD;
&#xD;
          3. Patients with ASA classification &gt; 3&#xD;
&#xD;
          4. Albumin &lt; 30 g/liter&#xD;
&#xD;
          5. Patient has a diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel&#xD;
             perforation, ischemic bowel, carcinomatosis or extensively spread inflammatory bowel&#xD;
             disease&#xD;
&#xD;
          6. Patients has a diagnosis of coagulopathy, thrombocytopenia, immune suppression&#xD;
&#xD;
          7. BMI â‰¥ 40&#xD;
&#xD;
          8. Patient is going through another surgical procedure (other than ileostomy,&#xD;
             adhesiolysis) during the surgery.&#xD;
&#xD;
          9. The patient is currently participating in another investigational drug or device study&#xD;
             unless pre-approved by the sponsor.&#xD;
&#xD;
         10. Patient has been taking regular systemic/ steroid medication in the last 6 months.&#xD;
&#xD;
         11. Patients is taking antimetabolites or antiplatelet agents.&#xD;
&#xD;
         12. Patient has preexisting sphincter problems&#xD;
&#xD;
         13. Patient has evidence of extensive local disease in the pelvis or has undergone a prior&#xD;
             pelvic anastomosis.&#xD;
&#xD;
         14. Patients with massive diverticulosis at the sigmoid/descending colon (viewed on&#xD;
             preoperative CT)&#xD;
&#xD;
         15. Any condition or abnormality which in the opinion of the investigator may jeopardize&#xD;
             the patient's safe participation or the quality of the data&#xD;
&#xD;
         16. Pregnant or nursing female patients. Female patients of child-bearing potential must&#xD;
             have a negative pregnancy test done within 7 days prior to surgical procedure per site&#xD;
             standard test.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan Elsner, PhD, MBA</last_name>
    <phone>617-855-5566</phone>
    <email>jonathan@colospan.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Orit Katzir, MSc</last_name>
    <email>orit@colospan.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California Irvine</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Balangue</last_name>
      <phone>714-509-2948</phone>
      <email>balanguj@hs.uci.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Carmichael, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado University Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Pina</last_name>
      <phone>303-724-7803</phone>
      <email>andrea.pinalimones@cuanschutz.edu</email>
    </contact>
    <contact_backup>
      <last_name>Micaela Galloway</last_name>
      <phone>(303) 724-2755</phone>
      <email>Micaela.galloway@cuanschutz.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jon Vogel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Birnbaum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brandon Chapman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin McCarter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kayla Woods</last_name>
      <phone>407-303-2800</phone>
      <phone_ext>1103878</phone_ext>
      <email>kayla.woods@adventhealth.com</email>
    </contact>
    <investigator>
      <last_name>John Monson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Trachtenberg</last_name>
      <phone>502-852-1671</phone>
      <email>laura.trachtenberg@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Susan Galandiuk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Russell Farmer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tyler Elliss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Jorden, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Kavalukas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alana Johnson</last_name>
      <email>AJohns60@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Craig Reickert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shawn Webb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Surya Nalamati, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Megumi Asai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amalia Stefanou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edwin Itenberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Bank Hospital - M Health Fairview University of Minnesota Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Jannatpour</last_name>
      <email>sjannatp@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dave Ankarlo</last_name>
      <phone>612-626-2498</phone>
      <email>anka0004@umn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Wolfgang Gaertner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyrus Jahansouz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elliot Arsoniadis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Genevieve Melton-Meaux, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Madoff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York-Presbyterian / Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koianka Ivanova, PhD</last_name>
      <phone>646-962-2342</phone>
      <email>kivanova@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Alessio Pigazzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lea Lowenfeld, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly Garrett, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Milson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Parul Shukla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heather Yeo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lifespan &amp; Brown Surgical Associates</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Salerno</last_name>
      <phone>401-444-7148</phone>
      <email>melanie.salerno@brownphysicians.org</email>
    </contact>
    <investigator>
      <last_name>Steven Schechter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Klipfel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Health</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzy Slomiak, CCRP</last_name>
      <phone>801-213-1223</phone>
      <email>Suzy.Slomiak@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Bartley Pickron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julio Cesar Delgado, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jessica Cohan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lyen Camille Huang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Be'er Sheva</city>
        <zip>85025</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilia Pinsk, MD</last_name>
      <phone>972-8-6400250</phone>
      <email>IliaPi@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Elchanan Quint, MD</last_name>
      <email>Elchananq@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>8250490</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wisam Khoury, MD</last_name>
      <phone>+972-4-8250490</phone>
      <email>WisamK@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Dganit Sivan</last_name>
      <email>dganitsi@clalit.org.il</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nir Wasserberg, MD</last_name>
      <phone>+972-3-9376202</phone>
      <email>nirw@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Milano</city>
        <state>Lombardy</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonino Spinelli, MD</last_name>
      <phone>+39 02 82247776</phone>
      <email>antonino.spinelli@hunimed.eu</email>
    </contact>
    <contact_backup>
      <last_name>Annalisa Maroli</last_name>
      <email>annalisa.maroli@cancercenter.humanitas.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://stomachoice.com/</url>
    <description>U.S. Clinical Study Website</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 1, 2019</study_first_submitted>
  <study_first_submitted_qc>December 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2019</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anastomosis</keyword>
  <keyword>leak</keyword>
  <keyword>mesorectal</keyword>
  <keyword>ileostomy</keyword>
  <keyword>colostomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

